Summary

The product Proviron, submitted by lemon@arailpharma.me, underwent independent testing to verify its composition and potency. The sample was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The test confirmed the presence of Mesterolone, with a measured concentration of 30.16 mg.

The testing process began on 27 August 2024, with the sample received on 19 September 2024, and analysis completed on 24 September 2024. While the results confirm the presence of Mesterolone, the lack of manufacturer and batch details raises concerns about product traceability. Independent third-party testing remains crucial to ensure reliability and consistency in the broader market.


Detailed Report

Product Overview

Testing Details

Testing Results


Verification Details


Evaluation of Manufacturer-Submitted Testing

This analysis confirms the presence of Mesterolone in the tested product; however, the lack of manufacturer and batch information makes it difficult to assess consistency. Additionally, without a stated dosage specification, accuracy cannot be fully verified. While Janoshik Analytical is known for transparent testing, independent validation through third-party labs across multiple samples is necessary to confirm product reliability.


Conclusion

The test confirms that Proviron contains Mesterolone (30.16 mg), but without batch identification or a manufacturer, evaluating quality control across multiple units is challenging. This report is shared to support educational efforts and harm reduction, helping consumers make informed decisions about anabolic steroid products.


Disclaimer

This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may have inherent biases, but it still provides valuable insights when cross-checked with independent analysis. Readers should interpret this information critically and responsibly.